CDKN1A and colorectal cancer: By evaluating the expression of BRIX1 and p21 in 62 colorectal cancer samples, we found that elevated levels of BRIX1 were associated with advanced TNM stages and a poor prognosis (Figure 6H; Table S3, Supporting Information), while high levels of p21 correlated with a favorable prognosis (Figure 6I).